Genes in the spondyloarthropathies

Rheum Dis Clin North Am. 1998 Nov;24(4):845-63. doi: 10.1016/s0889-857x(05)70045-4.

Abstract

Ankylosing spondylitis is a highly genetic disease, with up to 98% of the population variance genetically determined. The major genetic effect arises from HLA-B27, but other HLA class I molecules, including HLA-B60, also play a role. HLA class II association may indicate either an independent effect for these genes or the existence of extended MHC haplotype containing other relevant genetic loci. The HLA-linked component of the genetic contribution to AS is substantially less than 50%, and preliminary analysis of affected sibling pairs by whole genome screening has revealed several potential regions of interest. The next 5 years should lead to the confirmation of some of these linkages, their refinement, and the testing of candidate genes within them. Ultimately, a better understanding of the genetic etiology of AS should yield insight into the pathogenic mechanisms and the development of novel strategies for treatment and prevention.

Publication types

  • Review

MeSH terms

  • Genetic Testing
  • HLA-B27 Antigen / genetics*
  • Humans
  • Spondylitis, Ankylosing / genetics*

Substances

  • HLA-B27 Antigen